Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

Table 3 Clinical outcomes

	2-year rates	5-year rates
Overall survival	65.7%	50.8%
Bladder cancer specific survival	77.3%	67.3%
Survival with intact bladder^*	64.2%	49.0%
Local-regional control	69.8%	61.7%
Distant-metastasis-free survival	73.5%	67.1%
Progression-free survival	51.9%	39.9%

*Only one patient with local failure received radical cystectomy as salvage treatment.

ISSN: 1748-717X